Genworth Financial authorizes extra $500 million for share repurchases
- Genworth Financial authorizes an additional $500 million for share repurchases
- Prior $350M program saw 30 million shares bought for $262 million as of Sept 1, 2026
- CEO cites Enact’s higher capital returns in 2026 as supporting future cash flows
- Funding will come from holding company cash and Enact dividends, excluding AXA litigation proceeds

*this image is generated using AI for illustrative purposes only.
Genworth Financial, Inc. (NYSE: GNW) announced its Board of Directors has authorized an additional $500 million for the repurchase of common stock shares.
The expansion reinforces the company’s capital return strategy. As of September 1, 2026, approximately 30 million shares had been acquired at an aggregate cost of $262 million under the prior $350 million authorization, leaving roughly $88 million remaining.
Capital Return Strategy
CEO Tom McInerney stated the move reflects confidence in Genworth’s financial position and ability to return capital. He noted that Enact Holdings, Inc.’s plans for higher capital returns in 2026 strengthen expected cash flows.
Repurchases will be funded from current holding company cash and future cash flows from Enact. The company clarified that these plans do not incorporate potential proceeds from AXA litigation.
Program Details
| Metric | Value |
|---|---|
| New Authorization | $500 million |
| Prior Authorization | $350 million |
| Shares Repurchased (Prior) | 30 million |
| Cost of Prior Repurchases | $262 million |
| Remaining (Prior Auth) | $88 million |
Purchases may occur via open market transactions, private negotiations, or Rule 10b5-1 plans. The authorization has no expiration date and may be modified or terminated at any time.
How might the timing and pace of Genworth's $500 million share repurchases be influenced by the outcome of the ongoing AXA litigation?
What specific metrics will Genworth use to balance its increased capital return strategy with its long-term obligations as a life insurance provider?
How could Enact Holdings' projected higher capital returns in 2026 impact Genworth's liquidity and ability to sustain this new repurchase authorization?




























